✦ LIBER ✦

90 CHANGE OF BONE MINERAL DENSITY AFTER ONE-YEAR ALENDRONATE TREATMENT IN PREMENOPAUSAL WOMEN WITH LOW BONE DENSITY

✍ Scribed by Jung, H.

Book ID: 123036917
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 69 KB
Volume: 71
Category: Article
ISSN: 0378-5122
DOI: 10.1016/S0378-5122(12)70201-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of premenopausal women with lo

Treatment of premenopausal women with low bone mineral density

✍ Adi Cohen; Elizabeth Shane 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 163 KB

Are menopausal symptoms associated with

Are menopausal symptoms associated with bone mineral density and changes in bone mineral density in premenopausal women?

✍ Loran M Salamone; Edward Gregg; Randi L Wolf; Robert S Epstein; Dennis Black; Li 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P292 Low bone mineral density in premeno

P292 Low bone mineral density in premenopausal women with major depression

✍ R. Leo; M. Tesauro; S. Rizza; E. Fortuna; F. Bianchi; A. Bertoli; C. Pecchioli; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Low bone mineral density and high bone m

Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression

✍ Milan Petronijević; Nataša Petronijević; Maja Ivković; Dušan Stefanović; Nevena 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Changes of femoral periprosthetic bone m

Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty

✍ Mohammad Arabmotlagh; Mathias Pilz; Jörg Warzecha; Michael Rauschmann 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

## Abstract Earlier osteodensitometric results of femoral periprosthetic bone showed that postoperative antiresorptive treatment with alendronate following total hip arthroplasty (THA) reduces the periprosthetic bone loss that commonly occurs in the first months after surgery. However, whether alen

Denosumab (AMG 162) Inhibition of Rank L

Denosumab (AMG 162) Inhibition of Rank Ligand Increases Bone Mineral Density After Two Years of Treatment in Postmenopausal Women with Low Bone Mineral Density

✍ Lewiecki, E.M.; Miller, P.D.; McClung, M.R.; Cohen, S.B.; Liu, Y.; Wang, A.; Fit 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB